Events

Upcoming Events

There are currently no upcoming events,
but check back for updates.

Past Events

Leveraging long-term health data and exome sequencing for autism-related gene discovery

David Ledbetter, Ph.D., FACMG Chief Clinical Officer, Dascena

On 11 October 2017, David Ledbetter discussed the progress made by Geisinger Health System’s Precision Health Center – in partnership with Regeneron Genetics Center – towards advancing research and innovation by leveraging electronic health data and exome sequence data. Such an approach has already led to the successful identification of new drug targets and improved prevalence estimates of common Mendelian conditions, including familial hypercholesterolemia, BRCA-related cancers and Lynch syndrome, as well as autism spectrum and neuropsychiatric copy number variant disorders.

What can genetics tell us about autism spectrum disorder?

Stephan Sanders, B.M.B.S., Ph.D.Professor of Paediatric Neurogenetics, University of Oxford

On 22 March 2017, Stephan Sanders presented an update on the current state of genetics research in autism, highlighting some of the key findings that remain to be discovered, and discussing how these findings could ultimately benefit individuals with autism and their families.

Exploiting genetics to identify environmental risks for autism

Mark Zylka, Ph.D.Director, UNC Neuroscience Center, W.R. Kenan, Jr. Distinguished Professor, Department of Cell Biology & Physiology, University of North Carolina at Chapel Hill

On 22 February 2017, Mark Zylka described how candidate environmental risk factors for autism can be identified rationally, by pinpointing chemicals that interfere with the same molecular pathways that are affected in individuals with autism.

Genomic insights into human cortical development and neurodevelopmental disease

Arnold Kriegstein, M.D., Ph.D.Professor, Department of Neurology and Founding Director, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco

On 1 February 2017, Arnold Kriegstein described recent advances in our understanding of the unique features of human cortical development and discussed insights into the origins of neurodevelopmental disorders.

Potholes and progress on the road to translational treatments in autism spectrum disorder

Jeremy Veenstra-VanderWeele, M.D.Ruane Professor for the Implementation of Science for Child and Adolescent Mental Health, Columbia University Medical Center
Director, Division of Child & Adolescent Psychiatry, New York-Presbyterian/Morgan Stanley Children’s Hospital, Columbia University/New York State Psychiatric Institute

On 25 January 2017, Jeremy Veenstra-VanderWeele outlined critical challenges to translating genomic, cellular, and animal model research into new treatments for autism spectrum disorder.

  • Previous Page
  • Viewing
  • Next Page
Subscribe to our newsletter and receive SFARI funding announcements and news